Skip header and navigation
Did you mean topic:"colitic"? Also try colitic.

Narrow By

2 records – page 1 of 1.

Diet guidelines for ileoanal pouch

https://libcat.nshealth.ca/en/permalink/chpams35061
Nova Scotia Health Authority. Central Zone. Food and Nutrition Services. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
0555
Available Online
View Pamphlet
Tips to control gas, bloating, and diarrhea are given. Good food choices after surgery are listed as well as a list of foods to stay away from for at least 4 weeks after surgery.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Food and Nutrition Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Colonic Pouches
Proctocolectomy, Restorative
Colitis, Ulcerative - diet therapy
Subjects (LCSH)
Restorative Proctocolectomy
Digestive organs--Diseases
Specialty
Food and nutrition
Abstract
Tips to control gas, bloating, and diarrhea are given. Good food choices after surgery are listed as well as a list of foods to stay away from for at least 4 weeks after surgery.
Responsibility
Prepared by: Food and Nutrition Services
Pamphlet Number
0555
Less detail

Vedolizumab (Entyvio) therapy

https://libcat.nshealth.ca/en/permalink/chpams35620
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1623
Available Online
View Pamphlet
Vedolizumab (Entyvio┬«) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when und…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Gastrointestinal Agents
Colitis, Ulcerative - drug therapy
Crohn Disease - drug therapy
Subjects (LCSH)
Gastrointestinal agents
Ulcerative colitis
Crohn's disease
Specialty
Medications
Abstract
Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when undergoing this treatment are provided.
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1623
Less detail